Lexicon战略的核心是与诺和诺德公司达成的LX9851全球独家许可协议，这是一种首创的、口服生物利用度高的ACSL5抑制剂，正在开发用于肥胖和体重管理。该协议为Lexicon提供了实质性的财务支持，包括7500万美元的预付款和近期里程碑付款，潜在总付款高达10亿美元，外加分级特许权使用费。

今年1月，Lexicon宣布已收到美国FDA的监管反馈，上述2项3期临床研究（SOLOIST，SCORED）的结果可以支持sotagliflozin（索格列净）新药申请（NDA）提交 ...

In December 2023, we published a revised edition of the Lexicon as an eBook, which includes updated entries for 104 of the most salient terms we have collected over the past 20 years. Please ...

Find the latest Lexicon Pharmaceuticals, Inc. (LXRX) stock quote, history, news and other vital information to help you with your stock trading and investing.

THE WOODLANDS, Texas, July 18, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced that data from a study of patients describing the impact of diabetic peripheral neuropathic ...

Lexicon Pharmaceuticals (NASDAQ: LXRX) presented its first quarter 2025 earnings on May 13, highlighting financial restructuring efforts and strategic partnerships amid ongoing revenue challenges.

Little Rock, Ark.-based Lexicon Inc., a provider of construction management, steel fabrication, erection, mechanical ...

Lexicon has worked with Stanford University linguistic professors, including Dr. William Leben to understand how sound symbolism affects consumer reactions to brand names.

Listen to Lexicon Valley Episode No. 8: When Nouns Grew Genitals Subscribe in iTunes ∙ RSS feed ∙ Download ∙ Play in another tab ∙ Play in Stitcher Languages all across the world have what ...